---
$id: https://graph.org.ai/products/commodity/51171714
$type: Product
source: UNSPSC
code: "51171714"
title: "Racecadotril"
class: "51171700"
classTitle: "Antidiarrheals"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Racecadotril

**UNSPSC Code**: 51171714
**Class**: [Antidiarrheals](Antidiarrheals.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a protease inhibitor and antidiarrheal agent with the molecular formula C21H23NO4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 76K53XP4TO, chemically known as glycine, n-(2-((acetylthio)methyl)-1-oxo-3-phenylpropyl)-, phenylmethyl ester but generally known as racecadotril, which bears US NIH Compound Identifier 107751. European Medicines Agency schedules Racecadotril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12435MIG. The term RACECADOTRIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 10, No. 3, 1996, List 36). RACECADOTRIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule racecadotril under HS 29309085 and SITC 51549. As of Q4 2014, RACECADOTRIL remains the US FDA Preferred Term for this commodity. Racecadotril bears US NLM identifiers UMLS ID C0050461 and NCI Concept Code C66503. SMILES: S(CC(CC1CCCCC1)C(=O)NCC(=O)OCC1CCCCC1)C(=O)C.

